Scientists at the University at Buffalo School of Medicine and Biomedical Sciences have identified the mechanisms behind a genetic mutation that produces certain autistic behaviors in mice, as well as therapeutic strategies to restore normal behaviors.
Thirty-two doctoral, 35 master’s and 150 baccalaureate candidates were eligible to receive degrees in biomedical science fields during the May commencement ceremony.
Two expert reviewers for the global literature review service F1000Prime have recommended a University at Buffalo paper identifying molecular mechanisms affected by the local anesthetic bupivacaine.
University at Buffalo researchers have identified the minimum genetic requirement needed to generate retinal ganglion cells — key neuronal cells that connect the eye’s retina to the brain.
University at Buffalo researchers are the first to identify solifenacin as a drug target to promote stem cell therapy for myelin-based disease, such as multiple sclerosis.
Nine faculty and one staff member from the School of Medicine and Biomedical Sciences were among those honored for notable achievement and service at the 11th annual UB Celebration of Faculty and Staff Academic Excellence.
Along with her trainees, Gabriela K. Popescu, PhD, professor of biochemistry, organized an international meeting of researchers studying glutamate-gated neurotransmitter receptors.
A recent graduate, doctoral candidates and postdoctoral scholars in the University at Buffalo’s Neuroscience Program have received Beverly Petterson Bishop and Charles W. Bishop Neuroscience Fund Awards.